Efficacy and Tolerability of Riluzole in Treatment Resistant Depression
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This study aims to examine the antidepressant efficacy of riluzole, employing a randomized,
double-blind, placebo-controlled, adjunctive trial in treatment-resistant major depressive
disorder (TRD).